Intensive therapies for mantle cell lymphoma: time for a disease-specific approach?

Smith Stephen D, Sweetenham John W

Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

Leuk Lymphoma. 2010 Mar;51(3):357-9. doi: 10.3109/10428191003672149.

Abstract

摘要

相似文献

Leuk Lymphoma. 2010 Mar;51(3):357-9. doi: 10.3109/10428191003672149.

Semin Oncol. 2002 Feb;29(1 Suppl 2):56-69.

Clin Lymphoma. 2002 Sep;3(2):90-6. doi: 10.3816/clm.2002.n.014.

Blood. 2015 Jan 1;125(1):48-55. doi: 10.1182/blood-2014-05-521898. Epub 2014 Dec 11.

Hematology Am Soc Hematol Educ Program. 2004:221-36. doi: 10.1182/asheducation-2004.1.221.

Semin Oncol. 2004 Feb;31(1 Suppl 2):2-6.

Leuk Lymphoma. 2009 Aug;50(8):1249-56. doi: 10.1080/10428190903040030.

Leuk Lymphoma. 2009 Mar;50(3):463-5. doi: 10.1080/10428190802641979.

Leuk Lymphoma. 2014 Apr;55(4):802-10. doi: 10.3109/10428194.2013.815349. Epub 2013 Aug 13.

Leuk Lymphoma. 2011 Mar;52(3):387-93. doi: 10.3109/10428194.2010.534518. Epub 2010 Dec 6.

Zhonghua Xue Ye Xue Za Zhi. 2016 Jun 14;37(6):529-31. doi: 10.3760/cma.j.issn.0253-2727.2016.06.019.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。